Revascularization

Contributing journals to this collection:
JAMA & Archives Journals

Citations 131-140 of 350 total displayed.

Past content

Original Contributions
Effects of Fondaparinux on Mortality and Reinfarction in Patients With Acute ST-Segment Elevation Myocardial Infarction: The OASIS-6 Randomized Trial

The OASIS-6 Trial Group*
JAMA 2006; 295: 1519-1530. [Abstract] [Full text] [PDF]  

Original Contributions
Abciximab in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention After Clopidogrel Pretreatment: The ISAR-REACT 2 Randomized Trial

Adnan Kastrati; Julinda Mehilli; Franz-Josef Neumann; Franz Dotzer; Jurriën ten Berg; Hildegard Bollwein; Isolde Graf; Maryam Ibrahim; Jürgen Pache; Melchior Seyfarth; Helmut Schühlen; Josef Dirschinger; Peter B. Berger; Albert Schömig; for the Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment 2 (ISAR-REACT 2) Trial Investigators
JAMA 2006; 295: 1531-1538. [Abstract] [Full text] [PDF]  

Editorials
Clopidogrel Treatment Prior to Percutaneous Coronary Intervention: When Enough Isn't Enough

Steven R. Steinhubl; Richard Charnigo
JAMA 2006; 295: 1581-1582. [Extract] [Full text] [PDF]  

Original Contributions
Paclitaxel-Eluting Stents vs Vascular Brachytherapy for In-Stent Restenosis Within Bare-Metal Stents: The TAXUS V ISR Randomized Trial

Gregg W. Stone; Stephen G. Ellis; Charles D. O’Shaughnessy; Steven L. Martin; Lowell Satler; Thomas McGarry; Mark A. Turco; Dean J. Kereiakes; Lynne Kelley; Jeffrey J. Popma; Mary E. Russell; for the TAXUS V ISR Investigators
JAMA 2006; 295: 1253-1263. [Abstract] [Full text] [PDF]  

Original Contributions
Sirolimus-Eluting Stents vs Vascular Brachytherapy for In-Stent Restenosis Within Bare-Metal Stents: The SISR Randomized Trial

David R. Holmes Jr; Paul Teirstein; Lowell Satler; Michael Sketch; James O’Malley; Jeffery J. Popma; Richard E. Kuntz; Peter J. Fitzgerald; Hong Wang; Eileen Caramanica; Sidney A. Cohen; for the SISR Investigators
JAMA 2006; 295: 1264-1273. [Abstract] [Full text] [PDF]  

Editorials
Brachytherapy for In-Stent Restenosis: A Distant Second Choice to Drug-Eluting Stent Placement

Debabrata Mukherjee; David J. Moliterno
JAMA 2006; 295: 1307-1309. [Extract] [Full text] [PDF]  

Original Investigations
Contribution of Infection to Increased Mortality in Women After Cardiac Surgery

Mary A. M. Rogers; Kenneth M. Langa; Catherine Kim; Brahmajee K. Nallamothu; Laurence F. McMahon Jr; Preeti N. Malani; Brant E. Fries; Samuel R. Kaufman; Sanjay Saint
Arch Intern Med 2006; 166: 437-443. [Abstract] [Full text] [PDF]  

Original Contributions
Sirolimus- vs Paclitaxel-Eluting Stents in De Novo Coronary Artery Lesions: The REALITY Trial: A Randomized Controlled Trial

Marie-Claude Morice; Antonio Colombo; Bernhard Meier; Patrick Serruys; Corrado Tamburino; Giulio Guagliumi; Eduardo Sousa; Hans-Peter Stoll; for the REALITY Trial Investigators
JAMA 2006; 295: 895-904. [Abstract] [Full text] [PDF]  

Editorials
Wish List and REALITY: Choice of Stents and End Points for Treatment of De Novo Coronary Artery Lesions

Sorin J. Brener
JAMA 2006; 295: 937-938. [Extract] [Full text] [PDF]  

Medical News & Perspectives
Progress in Percutaneous Heart Procedures Leads to Update in Clinical Guidelines

Mike Mitka
JAMA 2006; 295: 263-264. [Extract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35